By otakuyassine3@gmail.com 
Compass Wealth Management LLC reduced its position in Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 21.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 152,478 shares of the company’s stock after selling 40,650 shares during the quarter. Compass Wealth Management LLC owned about 0.09% of Option Care Health worth $3,537,000 at the end of the most recent reporting period.
A number of other hedge funds have also modified their holdings of OPCH. UMB Bank n.a. grew its position in Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after buying an additional 346 shares during the last quarter. GAMMA Investing LLC boosted its stake in shares of Option Care Health by 110.6% during the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after acquiring an additional 471 shares in the last quarter. Lindenwold Advisors INC grew its holdings in shares of Option Care Health by 5.4% in the 3rd quarter. Lindenwold Advisors INC now owns 9,548 shares of the company’s stock worth $299,000 after acquiring an additional 489 shares during the period. Sheets Smith Wealth Management increased its stake in Option Care Health by 2.4% in the 4th quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company’s stock valued at $553,000 after purchasing an additional 550 shares in the last quarter. Finally, Trust Point Inc. raised its holdings in Option Care Health by 2.6% during the third quarter. Trust Point Inc. now owns 24,124 shares of the company’s stock worth $755,000 after purchasing an additional 622 shares during the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.
Option Care Health Stock Performance
NASDAQ OPCH opened at $30.33 on Friday. The business’s 50-day simple moving average is $24.42 and its 200-day simple moving average is $27.82. The firm has a market capitalization of $5.16 billion, a P/E ratio of 25.49, a P/E/G ratio of 2.11 and a beta of 1.31. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $34.63. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.
Insider Buying and Selling at Option Care Health
In related news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the business’s stock in a transaction on Friday, November 8th. The shares were bought at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the transaction, the director now directly owns 326,334 shares of the company’s stock, valued at $7,355,568.36. This trade represents a 15.18 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.64% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
Several research firms have recently issued reports on OPCH. UBS Group initiated coverage on Option Care Health in a research note on Thursday, December 5th. They set a “neutral” rating and a $26.00 price target for the company. JMP Securities restated a “market outperform” rating and set a $30.00 price objective (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Truist Financial reduced their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $38.00 to $27.00 in a research report on Monday, November 4th. Finally, Bank of America upgraded Option Care Health from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $32.25.
Check Out Our Latest Analysis on OPCH
About Option Care Health
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Stories
Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH – Free Report).
Receive News & Ratings for Option Care Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Option Care Health and related companies with MarketBeat.com’s FREE daily email newsletter.